Backed into a corner, Thailand’s action is justified

Backed into a corner, Thailand's action is justified -, June 25, 2007
Drug company Abbott Laboratories has backed Thailand into a corner over the pricing of an HIV/AIDS drug, argue Paul Cawthorne and colleagues in this Lancet Infectious Diseases editorial.
Abbott, say the authors, ignored requests to make a newer version of the second-line drug lopinavir-ritonavir available and affordable in Thailand, despite the drug's advantages for tropical countries — no need for refrigeration, no food restrictions and a lower pill requirement...
This entry was posted in Drugs. Bookmark the permalink.

Leave a Reply

Your email address will not be published.

This site uses Akismet to reduce spam. Learn how your comment data is processed.